DarioHealth Corp.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $64.2M
- Price
- $6.08
- % Change (Daily % change from the live per-ticker quote feed.)
- +1.00%
- Volume
- 2.6K
About
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
Quick stats
Shares outstanding10.6M
Computed float8.1M
Float / shares76.4%
Cash runway (months)14.9
Key info
SectorHealthcare
IndustryMedical - Specialties
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001533998
Websitehttps://www.dariohealth.com
AI Summary
AI-generated1/27
minorbullishoperations update
DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs
DarioHealth announced an independent review by Aon's Managed Care Services Team concluding that evidence supports an estimated 2.5%-7.2% annual reduction in total healthcare costs across a covered population.
For a representative 20,000-life population, Aon estimated $3.8 million to $10.8 million in annual savings, and found $5,077 in annual savings and 23.5% fewer inpatient discharges per type 2 diabetes user versus matched non-users.
Aon noted the estimates may be conservative, adding 1.6-2.8 percentage points of potential savings from multi-condition management and physician access, for a potential total of 10% annual savings. However, the review was limited to materials identified or provided by Dario and did not independently verify underlying data — a meaningful caveat for payers evaluating the claims.
Red flags
- Aon did not independently verify underlying data or audit studies; review based on Dario-provided materials
- Estimates are not a guarantee of outcomes for any specific customer